LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Nov 15, 2019
Product Development
Chipping away at unreliable animal data
Emulate shows its Liver-Chip can predict clinical toxicities that don't occur in animal models
Read More
BioCentury
|
May 23, 2018
Distillery Techniques
Assays and screens; biomarkers
Read More
BioCentury
|
Feb 3, 2017
Clinical News
RG-101 regulatory update
Read More
BioCentury
|
Jul 18, 2016
Clinical News
RG-101: Additional Phase II data
Read More
BioCentury
|
Jul 11, 2016
Clinical News
RG-101: FDA hold
Read More
BioCentury
|
Jun 6, 2016
Company News
GlaxoSmithKline, Regulus deal
Read More
BioCentury
|
Jun 2, 2016
Translation in Brief
Setting boundaries
Stanford group finds toxicity ceiling for shRNA therapeutics
Read More
BioCentury
|
Apr 25, 2016
Clinical News
RG-101: Additional Phase II data
Read More
BioCentury
|
Feb 22, 2016
Clinical News
RG-101: Interim Phase II data
Read More
BioCentury
|
Feb 1, 2016
Clinical News
RG-101: Completed Phase II enrollment
Read More
Items per page:
10
1 - 10 of 34